First Time Loading...

Cytodyn Inc
OTC:CYDY

Watchlist Manager
Cytodyn Inc Logo
Cytodyn Inc
OTC:CYDY
Watchlist
Price: 0.14 USD -4.11% Market Closed
Updated: Apr 29, 2024

Cytodyn Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cytodyn Inc
Cash from Operating Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Cytodyn Inc
OTC:CYDY
Cash from Operating Activities
-$16.6m
CAGR 3-Years
46%
CAGR 5-Years
17%
CAGR 10-Years
-13%
Abbvie Inc
NYSE:ABBV
Cash from Operating Activities
$22.8B
CAGR 3-Years
9%
CAGR 5-Years
11%
CAGR 10-Years
14%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Operating Activities
$8B
CAGR 3-Years
-1%
CAGR 5-Years
-1%
CAGR 10-Years
10%
Amgen Inc
NASDAQ:AMGN
Cash from Operating Activities
$8.5B
CAGR 3-Years
-7%
CAGR 5-Years
-6%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Operating Activities
$3.5B
CAGR 3-Years
3%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Operating Activities
$4.6B
CAGR 3-Years
21%
CAGR 5-Years
16%
CAGR 10-Years
23%

See Also

What is Cytodyn Inc's Cash from Operating Activities?
Cash from Operating Activities
-16.6m USD

Based on the financial report for Nov 30, 2023, Cytodyn Inc's Cash from Operating Activities amounts to -16.6m USD.

What is Cytodyn Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-13%

Over the last year, the Cash from Operating Activities growth was 49%. The average annual Cash from Operating Activities growth rates for Cytodyn Inc have been 46% over the past three years , 17% over the past five years , and -13% over the past ten years .